These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32288914)

  • 1.
    Kulpa-Eddy J; Srinivas G; Halder M; Hill R; Brown K; Roth J; Draayer H; Galvin J; Claassen I; Gifford G; Woodland R; Doelling V; Jones B; Stokes WS
    Procedia Vaccinol; 2011; 5():60-83. PubMed ID: 32288914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress and future directions for reduction, refinement, and replacement of animal use in veterinary vaccine potency and safety testing: a report from the 2010 NICEATM-ICCVAM International Vaccine Workshop.
    Stokes WS; Kulpa-Eddy J; Brown K; Srinivas G; McFarland R
    Dev Biol (Basel); 2012; 134():9-21. PubMed ID: 22888590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-animal replacement methods for human vaccine potency testing: state of the science and future directions.
    McFarland R; Verthelyi D; Casey W; Arciniega J; Isbrucker R; Schmitt M; Finn T; Descamps J; Horiuchi Y; Sesardic D; Stickings P; Johnson NW; Lipscomb E; Allen D
    Procedia Vaccinol; 2011; 5():16-32. PubMed ID: 32288913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward.
    Stokes W; McFarland R; Kulpa-Eddy J; Gatewood D; Levis R; Halder M; Pulle G; Kojima H; Casey W; Gaydamaka A; Miller T; Brown K; Lewis C; Chapsal JM; Bruckner L; Gairola S; Kamphuis E; Rupprecht CE; Wunderli P; McElhinney L; De Mattia F; Gamoh K; Hill R; Reed D; Doelling V; Johnson N; Allen D; Rinckel L; Jones B
    Biologicals; 2012 Sep; 40(5):369-81. PubMed ID: 22884673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report on the international workshop on alternative methods for Leptospira vaccine potency testing: state of the science and the way forward.
    Stokes W; Srinivas G; McFarland R; Kulpa-Eddy J; Casey W; Walker A; Draayer H; Sebring R; Brown K; Balks E; Stirling C; Klaasen E; Hill R; Rippke B; Ruby K; Alt D; Mukhopadhyay S; Kojima H; Johnson N; Rinckel L; Doelling V; Jones B
    Biologicals; 2013 Sep; 41(5):279-94. PubMed ID: 23890729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving scientific and regulatory success in implementing non-animal approaches to human and veterinary rabies vaccine testing: A NICEATM and IABS workshop report.
    Poston R; Hill R; Allen C; Casey W; Gatewood D; Levis R; Mallet L; Smith D; Srinivas G; Stirling C; Allen D
    Biologicals; 2019 Jul; 60():8-14. PubMed ID: 31255474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3Rs implementation in veterinary vaccine batch-release testing: Current state-of-the-art and future opportunities. A webinar and workshop report.
    Viviani L; Balks E; Beken S; Brady AM; Clayton R; Cliquet F; Desmayanti L; Fragoeiro S; Hamtak TJ; John D; Jungbaëck C; Kalaivani M; Kross I; Lang C; Ria Isriyanthi NM; Mallet L; Milne C; Rubbrecht M; Siklódi B; Singh B; Srinivas GB; Stickings P; Stirling C; Sundram P; Szabó M; Thomas A; van den Berg M; Walker A; Philippe C; Vandeputte J
    Biologicals; 2023 Aug; 83():101695. PubMed ID: 37516084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report on the international workshop on alternatives to the murine histamine sensitization test (HIST) for acellular pertussis vaccines: state of the science and the path forward.
    Isbrucker R; Arciniega J; McFarland R; Chapsal JM; Xing D; Bache C; Nelson S; Costanzo A; Hoonakker M; Castiaux A; Halder M; Casey W; Johnson N; Jones B; Doelling V; Sprankle C; Rinckel L; Stokes W
    Biologicals; 2014 Mar; 42(2):114-22. PubMed ID: 24394373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three Rs potential in the development and quality control of immunobiologicals.
    Halder M
    ALTEX; 2001; 18 Suppl 1():13-47. PubMed ID: 11854853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potency testing of veterinary rabies vaccines: replacement of challenge by in vitro testing: considerations for development of alternative assays.
    Lewis CE; Fry AM; Hermann JR; Siev D; Dusek DM; Gatewood DM
    Dev Biol (Basel); 2012; 134():29-33. PubMed ID: 22888592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency testing of veterinary vaccines: the way from in vivo to in vitro.
    Romberg J; Lang S; Balks E; Kamphuis E; Duchow K; Loos D; Rau H; Motitschke A; Jungbäck C
    Biologicals; 2012 Jan; 40(1):100-6. PubMed ID: 22075457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern science for better quality control of medicinal products "Towards global harmonization of 3Rs in biologicals": The report of an EPAA workshop.
    Schutte K; Szczepanska A; Halder M; Cussler K; Sauer UG; Stirling C; Uhlrich S; Wilk-Zasadna I; John D; Bopst M; Garbe J; Glansbeek HL; Levis R; Serreyn PJ; Smith D; Stickings P
    Biologicals; 2017 Jul; 48():55-65. PubMed ID: 28596049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaborative study for the validation of cell line assays for in-process toxicity and antigenicity testing of Clostridium septicum vaccine antigens - Part 2: Optimisation of cell line assays.
    Behr-Gross ME; Siklodi B; Le Tallec D; Halder M; Manou I; Sinitskaya N; Bruckner L; Dalmadi B; Kiss L; Redhead K
    Pharmeur Bio Sci Notes; 2021; 2021():101-156. PubMed ID: 34078535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International regulatory requirements for Leptospira vaccine potency testing. Roundtable: current requirements and opportunity for harmonization.
    Draayer HA; Bruckner L; Peña-Moctezuma Ade L; Srinivas G
    Biologicals; 2013 Sep; 41(5):305-7. PubMed ID: 23890730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potency testing of veterinary vaccines, rabies vaccines as an example.
    Bruckner L; Palatini M; Ackermann M; Müller HK; McCullough K; Kihm U
    ALTEX; 1989; 6(2):46-58. PubMed ID: 11208274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities and strategies to further reduce animal use for Leptospira vaccine potency testing.
    Walker A; Srinivas GB
    Biologicals; 2013 Sep; 41(5):332-7. PubMed ID: 23891496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro potency assays for nonreplicating veterinary vaccines: comparison to in vivo assays and considerations in assay development.
    Levings RL; Henderson LM; Metz CA
    Vet Microbiol; 1993 Nov; 37(3-4):201-19. PubMed ID: 8116182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): a review of the ICCVAM test method evaluation process and current international collaborations with the European Centre for the Validation of Alternative Methods (ECVAM).
    Stokes WS; Schechtman LM; Hill RN
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():23-32. PubMed ID: 12513648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Veterinary vaccines: In-VITRO--International Veterinary Industry Test Replacement Organisation.
    Redhead K; Lucken R; van de Moer A; Houghton S; Simpson B; Cameron A; Monkton P; Hennesy K; Ellis C
    Dev Biol Stand; 1999; 101():261-6. PubMed ID: 10566800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECVAM's contributions to the implementation of the Three Rs in the production and quality control of biologicals.
    Halder M; Hendriksen C; Cussler K; Balls M
    Altern Lab Anim; 2002; 30(1):93-108. PubMed ID: 11827574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.